These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38604092)

  • 21. Synthetic MRI quantitative parameters in discriminating stage T1 nasopharyngeal carcinoma and benign hyperplasia: Combination with morphological features.
    Zhang H; Zhao J; Dai J; Chang J; Hu S; Wang P
    Eur J Radiol; 2024 Jan; 170():111264. PubMed ID: 38103492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status.
    Li X; Fan Z; Jiang H; Niu J; Bian W; Wang C; Wang Y; Zhang R; Zhang H
    Sci Rep; 2023 Oct; 13(1):17978. PubMed ID: 37864025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early-stage invasive ductal carcinoma: Association of tumor apparent diffusion coefficient values with axillary lymph node metastasis.
    Kim JY; Seo HB; Park S; Moon JI; Lee JW; Lee NK; Lee SW; Bae YT
    Eur J Radiol; 2015 Nov; 84(11):2137-43. PubMed ID: 26318821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive identification of HER2-zero, -low, or -overexpressing breast cancers: Multiparametric MRI-based quantitative characterization in predicting HER2-low status of breast cancer.
    Zhan T; Dai J; Li Y
    Eur J Radiol; 2024 Aug; 177():111573. PubMed ID: 38905803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
    Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
    Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time Course Changes of Synthetic Relaxation Time During Neoadjuvant Chemotherapy in Breast Cancer: The Optimal Parameter for Treatment Response Evaluation.
    Zhao R; Du S; Gao S; Shi J; Zhang L
    J Magn Reson Imaging; 2023 Oct; 58(4):1290-1302. PubMed ID: 36621982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive sentinel lymph nodes: a retrospective study.
    Murata T; Watase C; Shiino S; Kurita A; Ogawa A; Jimbo K; Iwamoto E; Yoshida M; Takayama S; Suto A
    World J Surg Oncol; 2022 Sep; 20(1):314. PubMed ID: 36171615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging.
    Razek AA; Lattif MA; Denewer A; Farouk O; Nada N
    Breast Cancer; 2016 May; 23(3):525-32. PubMed ID: 25763535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of T2* in differentiating metastatic from benign axillary lymph nodes in patients with breast cancer--a preliminary in vivo study.
    Li C; Meng S; Yang X; Wang J; Hu J
    PLoS One; 2014; 9(1):e84038. PubMed ID: 24454715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
    Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
    J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value for axillary lymph node metastases in early breast cancer: Based on contrast-enhanced ultrasound characteristics of the primary lesion and sentinel lymph node.
    Pang W; Wang Y; Zhu Y; Jia Y; Nie F
    Clin Hemorheol Microcirc; 2024; 86(3):357-367. PubMed ID: 37955082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic MRI and amide proton transfer-weighted MRI for differentiating between benign and malignant sinonasal lesions.
    Xiang Y; Zhang Q; Chen X; Sun H; Li X; Wei X; Zhong J; Gao B; Huang W; Liang W; Sun H; Yang Q; Ren X
    Eur Radiol; 2024 Oct; 34(10):6820-6830. PubMed ID: 38491129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nomogram Based on Breast MRI and Clinicopathologic Features for Predicting Axillary Lymph Node Metastasis in Patients with Early-Stage Invasive Breast Cancer: A Retrospective Study.
    Xue M; Che S; Tian Y; Xie L; Huang L; Zhao L; Guo N; Li J
    Clin Breast Cancer; 2022 Jun; 22(4):e428-e437. PubMed ID: 34865995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does axillary lymph node size predict better metastatic involvement than apparent diffusion coefficient (ADC) value in women with newly diagnosed breast cancer?
    Ramírez-Galván YA; Cardona-Huerta S; Elizondo-Riojas G; Álvarez-Villalobos NA; Campos-Coy MA; Ferrara-Chapa CM
    Acta Radiol; 2020 Nov; 61(11):1494-1504. PubMed ID: 32064890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative evaluation of meniscus injury using synthetic magnetic resonance imaging.
    Zhang L; Mai W; Mo X; Zhang R; Zhang D; Zhong X; Zhao S; Shi C
    BMC Musculoskelet Disord; 2024 Apr; 25(1):292. PubMed ID: 38622682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of Contrast-Enhanced Ultrasound Combined with Immune-Inflammatory Markers in Predicting Axillary Lymph Node Metastasis of Breast Cancer.
    Song Y; Liu J; Jin C; Zheng Y; Zhao Y; Zhang K; Zhou M; Zhao D; Hou L; Dong F
    Acad Radiol; 2024 Sep; 31(9):3535-3545. PubMed ID: 38918153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
    Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
    Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3.0 T relaxation time measurements of human lymph nodes in adults with and without lymphatic insufficiency: Implications for magnetic resonance lymphatic imaging.
    Crescenzi R; Donahue PM; Braxton VG; Scott AO; Mahany HB; Lants SK; Donahue MJ
    NMR Biomed; 2018 Dec; 31(12):e4009. PubMed ID: 30311705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.